Weave Communications, Inc. (WEAV) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance, strategic growth through AI and partnerships, and optimistic guidance. While there are concerns about unclear management responses on payment adoption and future investments, the overall sentiment remains positive due to expected revenue growth, profitability improvements, and strategic initiatives. The market strategy and shareholder return plan are well-received, with plans for increased leverage and focus on high-potential verticals. Despite some uncertainties, the positive outlook on growth and profitability, along with strategic developments, suggests a positive stock price movement.
Key Financial Performance
Revenue $61.3 million, accelerating year-over-year growth rate to 17.1%. This marks the 15th consecutive quarter of exceeding the top end of revenue guidance.
Gross Margin Reached a record high of 73%, more than 15 percentage points higher than at IPO 4 years ago. Improvements were driven by leveraging cloud data center costs and hardware amortization.
Free Cash Flow $5 million, reflecting disciplined execution and the efficiency and scalability of the business.
Payments Revenue Grew at more than double the rate of total revenue, driven by the launch of surcharging and bulk collection features.
Gross Revenue Retention Held steady at 90% in Q3, indicating strong customer retention.
Net Revenue Retention 94%, with a decrease due to lapping the effects of a price increase in Q2 2024 and higher churn in new verticals like specialty medical.
Operating Income $1.7 million, an improvement of $300,000 compared to Q3 2024, representing an operating margin of 2.7%.
Cash and Short-term Investments $80.3 million, an increase of more than $2 million sequentially, reflecting strong liquidity.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI receptionist: Expanded capabilities to handle incoming patient calls directly, intelligently route inquiries, and manage scheduling via voice or text. Strong interest from single-location customers and mid-market accounts.
Call intelligence: Analyzes call recordings to detect customer sentiment and identify patient needs and revenue opportunities. Expanded capabilities to unify human and AI-driven interactions.
Payments platform: Launched surcharging and bulk collection features to manage costs and save time for office staff.
Specialty medical vertical: Delivered record results with the highest number of medical location additions in company history. Represents a significant long-term opportunity as it is more than triple the size of dental, optometry, and veterinary combined.
Mid-market expansion: Signed a contract with a 600+ location specialty medical group, with potential to become one of the largest customers. Expanded traction across multiple healthcare segments.
Revenue growth: Generated $61.3 million in revenue, a 17.1% year-over-year growth rate. Achieved 15 consecutive quarters of exceeding revenue guidance.
Gross margin: Reached a record high of 73%, reflecting scalability and efficiency.
Free cash flow: Generated $5 million in free cash flow, demonstrating disciplined execution.
AI innovation: Focused on intelligent automation to transform patient communication and workflows. Expanded AI receptionist and call intelligence capabilities.
Integration partnerships: Launched multiple new integrations, doubling to quintupling sales of integrated solutions year-over-year.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Staffing shortages in SMB healthcare practices: More than 70% of SMB healthcare practices report difficulty in hiring and retaining front desk staff, which disrupts patient communication and daily operations. This remains the #1 operational challenge for these practices.
Regulatory compliance and security risks: Competitors may struggle to meet the high standards of security, regulatory compliance, and reliability required in healthcare, which are critical for maintaining customer trust and avoiding legal risks.
Churn in new verticals: Entering new verticals like specialty medical has led to higher churn and lower average sales prices initially, which could pressure overall retention metrics and financial performance.
Dependence on AI and automation: While AI and automation are central to Weave's strategy, over-reliance on these technologies could pose risks if they fail to meet customer expectations or if competitors develop superior solutions.
Economic uncertainties: Although not explicitly mentioned, economic uncertainties could impact customer acquisition and retention, especially in SMB markets that are sensitive to broader economic conditions.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance: The company is raising the midpoint of its full-year revenue guidance to a range of $238 million to $239 million. For Q4 2025, total revenue is expected to be in the range of $62.4 million to $63.4 million.
Non-GAAP Operating Income Guidance: The company is raising its full-year non-GAAP operating income guidance to a range of $3.3 million to $4.3 million. For Q4 2025, non-GAAP operating income is expected to be in the range of $1.5 million to $2.5 million.
AI and Automation Expansion: The company plans to expand the capabilities of its AI receptionist, including introducing voice capabilities later this quarter to handle incoming patient calls and route inquiries intelligently. Sales efforts for the AI receptionist will extend to new single-location customers in November.
Specialty Medical Vertical Growth: Specialty medical is emerging as a key growth driver, delivering record results with the highest number of medical location additions in company history. This vertical represents a significant long-term opportunity as it is more than triple the size of dental, optometry, and veterinary combined.
Mid-Market Growth: The mid-market segment continues to grow, with expanding traction across multiple healthcare segments. A recent contract with a 600-plus location specialty medical group highlights this growth, with the initial phase including 50 locations already onboarding.
Payments Platform Growth: Payments revenue is growing at more than double the rate of total revenue. Recent launches include surcharging and bulk collection features, which are expected to strengthen the value proposition for multi-location and enterprise customers.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you talk about what you're seeing from the TrueLark solution broadly and its integration with payments?
A:The company experienced strong volume growth in payments this quarter, with revenue growth more than doubling the total growth rate. TrueLark capabilities are on the roadmap, starting with a stand-alone product not yet integrated with payments. The company has begun upselling it to existing customers and introducing it to new single locations. An integrated solution called 'infusion' will combine TrueLark technology into the Weave inbox, followed by intelligent actions like automated workflows for payments and revenue cycle management. This functionality is expected to roll out over the next few quarters.
Q:Can you update us on group integration or implementations in specialty medical, particularly the ACI one?
A:The company continues to make progress in the mid-market, with strong sales and adoption in the ACI group. ACI selected Weave for its payment workflows and solutions, which have contributed to growth. The rollout is on track, and the management team is optimistic about the future, especially with the planned automated front desk and integrated inbox features.
Q:What is it going to take for payments adoption to really accelerate, and how will it benefit from TrueLark integration and other functionalities?
A:The key to accelerating payments adoption lies in nailing workflows and integrating with practice management software. The company has delivered on two top-requested features, including surcharging, which has shown positive results. The strategy of using authorized APIs for integrations is paying off. Automation technologies from TrueLark and organic development are expected to significantly unlock potential over the next few quarters.
Q:How do you balance the rollout of new integrations in specialty medical versus growing ASPs and customers in existing subverticals?
A:The company takes a programmatic approach, starting with the largest practice management software players and rolling out integrations. Integrations drive higher ASPs and retention rates. Existing customers often upgrade to integrated versions, which perform better. The company focuses on large players first and then expands to smaller ones.
Q:Can you break down the driver of success in specialty medical and how to replicate it across other verticals?
A:The company focuses on primary verticals like med spa, plastics, aesthetics, and therapy, which have significant opportunities. These verticals are roughly the size of dental, optometry, and vet combined, with less than 1% penetration. Integrations with EMRs and customer demand drive expansion. The approach is replicable, but the current focus is on capturing opportunities in these verticals.
Q:How is Weave differentiating its payments from legacy processors and modern vertical SaaS players?
A:Weave differentiates by integrating payment collection into existing interactions and communications managed by the front desk. This includes text-to-pay capabilities and online bill pay links. The focus is on collecting payments outside the practice walls, where Weave owns the interactions. Future plans include enhancing collection workflows through AI receptionist technology.
Q:What are your expectations for profitability and leverage moving beyond Q4?
A:The company is making targeted investments in go-to-market and engineering to enable integrations. These investments are expected to provide additional leverage in the model. The company is committed to balancing growth with incremental profitability and will provide more details on 2026 plans in the next call.
Q:Can you discuss the competitive landscape for the AI receptionist and its impact on practices?
A:The AI receptionist alleviates lower-value tasks, allowing front desk staff to focus on patient care and higher-value activities. This improves patient service and revenue capture for practices. The company plans to deliver increasing functionality over the next few quarters.
Q:How much of the success in payments is due to the new go-to-market focus versus new product capabilities?
A:The success is attributed to creating a stand-alone business unit for payments, understanding practice operations, designing workflows, and building a go-to-market engine. Advancing partnerships with practice management software platforms and delivering top-requested features also contributed to the success.
Q:What are your plans for investments in 2026?
A:The company is in the middle of planning for 2026. Investments will focus on opportunities, with targeted additions in sales and mid-market. The company aims to balance growth with profitability, leveraging scale within G&A to support investments. More details will be provided in the next call.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the percentage of the customer base using Weave for payments, stating only that it makes up less than 10% of revenue. Additionally, they did not provide clear guidance on the scale of investments planned for 2026, deferring specifics to the next call.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI receptionist
Brett
Conference
New York
SMB healthcare
TrueLark
Weave answer
Weave position
account
addition
advantage platform
answer rate
capability
compliance reliability
conversation
desk
example
extension practice
feature
forefront
foundation
healthcare practice
insight
intelligence
level
office staff
patient call
patient experience
phase
platform AI
position term
potential
practice opportunity
practice patient
purpose
quarter
road map
security
share practice
transformation
voice
WEAV Transcript
Weave Communications, Inc. (WEAV) Q1 2026 Earnings Call Transcript
Positive4-30
The earnings call highlights strong financial performance with 12% revenue growth and improved gross margins. Net loss reduction and a significant increase in adjusted EBITDA also support a positive outlook. Despite risks associated with non-GAAP metrics, these financial improvements and strategic partnerships, such as with CareCredit, are likely to drive a positive stock price movement over the next two weeks.
Weave Communications, Inc. (WEAV) Q4 2025 Earnings Call Transcript
Positive2-20
The earnings call reveals strong revenue growth, improved gross margins, and increased free cash flow, suggesting financial strength. The company is raising its revenue and operating income guidance, indicating confidence in future performance. Expansion in AI and specialty medical verticals, alongside a new CareCredit partnership, further supports growth prospects. Despite some uncertainties in growth rates and product impacts, the overall sentiment is positive due to strategic initiatives and financial improvements.
Weave Communications, Inc. (WEAV) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call highlights strong financial performance, strategic growth through AI and partnerships, and optimistic guidance. While there are concerns about unclear management responses on payment adoption and future investments, the overall sentiment remains positive due to expected revenue growth, profitability improvements, and strategic initiatives. The market strategy and shareholder return plan are well-received, with plans for increased leverage and focus on high-potential verticals. Despite some uncertainties, the positive outlook on growth and profitability, along with strategic developments, suggests a positive stock price movement.
Weave Communications, Inc. (WEAV) Q2 2025 Earnings Call Transcript
Positive8-1
The earnings call highlights strong growth in specialty medical, successful integration of TrueLark, and positive customer feedback. The company's strategic investments in R&D and sales/marketing, along with raised revenue guidance, indicate a positive outlook. While there are some uncertainties regarding AI adoption and macroeconomic impacts, overall, the sentiment is positive due to strong demand, growth opportunities, and strategic plans. The Q&A section reinforces confidence in the company's direction, with analysts showing interest in growth strategies and integration progress.
WEAV Slides
WEAV Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
